Schietinger A - Search Results

1

Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.

Chou CK, Schietinger A, Liggitt HD, Tan X, Funk S, Freeman GJ, Ratliff TL, Greenberg NM, Greenberg PD. Chou CK, et al. Among authors: schietinger a. J Immunol. 2012 Oct 15;189(8):3936-46. doi: 10.4049/jimmunol.1201415. Epub 2012 Sep 14. J Immunol. 2012. PMID: 22984076 Free PMC article.

2

Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state.

Schietinger A, Delrow JJ, Basom RS, Blattman JN, Greenberg PD. Schietinger A, et al. Science. 2012 Feb 10;335(6069):723-7. doi: 10.1126/science.1214277. Epub 2012 Jan 19. Science. 2012. PMID: 22267581 Free PMC article.

3

Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Schietinger A, Greenberg PD. Schietinger A, et al. Trends Immunol. 2014 Feb;35(2):51-60. doi: 10.1016/j.it.2013.10.001. Epub 2013 Nov 6. Trends Immunol. 2014. PMID: 24210163 Free PMC article. Review.

4

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.

Schietinger A, Philip M, Krisnawan VE, Chiu EY, Delrow JJ, Basom RS, Lauer P, Brockstedt DG, Knoblaugh SE, Hämmerling GJ, Schell TD, Garbi N, Greenberg PD. Schietinger A, et al. Immunity. 2016 Aug 16;45(2):389-401. doi: 10.1016/j.immuni.2016.07.011. Epub 2016 Aug 9. Immunity. 2016. PMID: 27521269 Free PMC article.

5

CD8⁺ T cell differentiation and dysfunction in cancer.

Philip M, Schietinger A. Philip M, et al. Among authors: schietinger a. Nat Rev Immunol. 2022 Apr;22(4):209-223. doi: 10.1038/s41577-021-00574-3. Epub 2021 Jul 12. Nat Rev Immunol. 2022. PMID: 34253904 Free PMC article. Review.

6

Priming of naive T cells inside tumors leads to eradication of established tumors.

Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX. Yu P, et al. Among authors: schietinger a. Nat Immunol. 2004 Feb;5(2):141-9. doi: 10.1038/ni1029. Epub 2004 Jan 4. Nat Immunol. 2004. PMID: 14704792 Free article.

7

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.

Zhang B, Bowerman NA, Salama JK, Schmidt H, Spiotto MT, Schietinger A, Yu P, Fu YX, Weichselbaum RR, Rowley DA, Kranz DM, Schreiber H. Zhang B, et al. Among authors: schietinger a. J Exp Med. 2007 Jan 22;204(1):49-55. doi: 10.1084/jem.20062056. Epub 2007 Jan 8. J Exp Med. 2007. PMID: 17210731 Free PMC article.

8

Equilibrium between host and cancer caused by effector T cells killing tumor stroma.

Zhang B, Zhang Y, Bowerman NA, Schietinger A, Fu YX, Kranz DM, Rowley DA, Schreiber H. Zhang B, et al. Among authors: schietinger a. Cancer Res. 2008 Mar 1;68(5):1563-71. doi: 10.1158/0008-5472.CAN-07-5324. Cancer Res. 2008. PMID: 18316622

9

Specificity in cancer immunotherapy.

Schietinger A, Philip M, Schreiber H. Schietinger A, et al. Semin Immunol. 2008 Oct;20(5):276-85. doi: 10.1016/j.smim.2008.07.001. Epub 2008 Aug 5. Semin Immunol. 2008. PMID: 18684640 Free PMC article. Review.

10

IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner.

Liu RB, Engels B, Schreiber K, Ciszewski C, Schietinger A, Schreiber H, Jabri B. Liu RB, et al. Among authors: schietinger a. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8158-63. doi: 10.1073/pnas.1301022110. Epub 2013 May 1. Proc Natl Acad Sci U S A. 2013. PMID: 23637340 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page